VLP Platform Technology
Platform Technology
Information
The iBio VLP platform is based on the production of non-enveloped virus-like particles composed of viral core proteins that self-assemble into spherical particles. This type of VLP is, by design, simpler, with one major protein component, more consistent to produce through production scale-up, and highly flexible for antigen display. Combined with the FastPharming technology, iBio's VLP platform is adaptable to new strains and outbreaks, and deployable with rapid scale-up and manufacturing set-up.
